Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Soft Tissue Injuries D017695 2 associated lipids
Optic Nerve Injuries D020221 4 associated lipids
Hyperuricemia D033461 4 associated lipids
Pneumonia, Pneumococcal D011018 3 associated lipids
Dictyocaulus Infections D004022 1 associated lipids
Bovine Virus Diarrhea-Mucosal Disease D001912 2 associated lipids
Jaundice, Obstructive D041781 2 associated lipids
Lymphoma, T-Cell, Cutaneous D016410 4 associated lipids
Leukostasis D018921 1 associated lipids
Pulmonary Atelectasis D001261 1 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Tselepis AD et al. Electrocardiographic alterations induced by AGEPC in Wistar rats in relation to its hypotensive and hematologic effects. 1987 Comp. Biochem. Physiol. C, Comp. Pharmacol. Toxicol. pmid:2885139
Nomura H Biological action and structural specificity of diacylglycerol in platelet activation. 1987 Kobe J Med Sci pmid:3695296
Hayashi M et al. Characterization of the activity of a platelet activating factor antagonist, CV-3988. 1987 Jpn. J. Pharmacol. pmid:2888915
McFall TL et al. Effect of group B streptococcal type-specific antigen on polymorphonuclear leukocyte function and polymorphonuclear leukocyte-endothelial cell interaction. 1987 Pediatr. Res. pmid:3037472
Grignani G and Jamieson GA Tissue factor-dependent activation of platelets by cells and microvesicles of SK-OS-10 human osteogenic sarcoma cell line. 1987 Invasion Metastasis pmid:3036740
Snyder F et al. Measurement of key enzyme activities involved in the metabolism of platelet activating factor. 1987 Meth. Enzymol. pmid:3037250
Ingraham LM et al. In vitro and in vivo effects of treatment by platelet-activating factor on N-formyl-met-leu-phe-mediated responses of polymorphonuclear leucocytes. 1987 Br. J. Haematol. pmid:3038160
Criscuoli M and Subissi A Paf-acether-induced death in mice: involvement of arachidonate metabolites and beta-adrenoceptors. 1987 Br. J. Pharmacol. pmid:2880624
Englberger W et al. Influence of lysophospholipids and PAF on the oxidative burst of PMNL. 1987 Int. J. Immunopharmacol. pmid:3038761
Handley DA et al. Inhibition by SRI 63-072 and SRI 63-119 of PAF-acether and immune complex effects in the guinea pig. 1987 Eur. J. Pharmacol. pmid:2959489
Doly M et al. Effects of platelet-activating factor on electrophysiology of isolated retinas and their inhibition by BN 52021, a specific PAF-acether receptor antagonist. 1987 Immunopharmacology pmid:3038784
Montrucchio G et al. In vitro oxytocic activity of platelet-activating factor on human myometrium. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960158
Homma H et al. Binding and internalization of platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine in washed rabbit platelets. 1987 J. Biol. Chem. pmid:3038889
Mallet AI et al. Platelet activating factor in chronic plaque psoriasis. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960170
Bourgain RH et al. Effect of ginkgolide PAF-acether antagonists on arterial thrombosis. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960196
Braquet P et al. Platelet-activating factor: a potential mediator of shock. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960197
Myers A et al. Pharmacological manipulation of platelet-activating factor toxicity in rodents. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960198
Casals-Stenzel J Triazolodiazepines are potent antagonists of platelet activating factor (PAF) in vitro and in vivo. 1987 Naunyn Schmiedebergs Arch. Pharmacol. pmid:3587377
Brambilla A et al. WEB 2086. A potent PAF antagonist exerts protective effect toward PAF-induced gastric damage. 1987 Pharmacol Res Commun pmid:3588650
Jancar S et al. Comparative effects of platelet activating factor, leukotriene D4 and histamine on guinea pig trachea, bronchus and lung parenchyma. 1987 Prostaglandins pmid:3588970
Malo PE et al. Enhancement of leukotriene D4-induced contraction of guinea-pig isolated trachea by platelet activating factor. 1987 Prostaglandins pmid:3588971
Joseph R et al. Sensitivity to PAF is increased in migraine patients. 1987 Thromb. Haemost. pmid:3590077
Valone FH Inhibition of platelet-activating factor binding to human platelets by calcium channel blockers. 1987 Thromb. Res. pmid:3590086
Tokumura A et al. Platelet aggregation induced by ether-linked phospholipids. 2. Mechanism of desensitization of rabbit platelets by platelet activating factor and reversibility of inhibitory actions of its antagonists. 1987 Thromb. Res. pmid:3590110
Bamford CH et al. Polymeric inhibitors of platelet aggregation. II. Copolymers of dipyridamole and related drugs with N-vinylpyrrolidone. 1987 Biochim. Biophys. Acta pmid:3828396
Shigenobu K et al. Potentiation by bovine serum albumin (BSA) of endothelium-dependent vasodilator response to acetyl glyceryl ether phosphorylcholine (AGEPC). 1987 J. Pharmacobio-dyn. pmid:3625454
Jensen NJ et al. FAB MS/MS for phosphatidylinositol, -glycerol, -ethanolamine and other complex phospholipids. 1987 Lipids pmid:3626775
Cox CP and Wood KL Selective antagonism of platelet-activating factor (PAF)-induced aggregation and secretion in washed rabbit platelets by CV-3988, L-652731, triazolam and alprazolam. 1987 Thromb. Res. pmid:3629553
Ostermann G et al. Plasma from atherosclerotic patients exerts an increased degradation of platelet-activating factor. 1987 Thromb. Res. pmid:3629555
Pettipher ER et al. PAF-acether in chronic arthritis. 1987 Agents Actions pmid:3630862
Haroldsen PE et al. Metabolism of platelet-activating factor in isolated perfused rat lung. 1987 J. Clin. Invest. pmid:3108322
Hansen JF and Hansen BF [Unstable angina pectoris, acute myocardial infarct, sudden heart death. Patho-anatomy and pathophysiology]. 1987 Ugeskr. Laeg. pmid:3324429
Bienenstock J et al. Mast cell involvement in various inflammatory processes. 1987 Am. Rev. Respir. Dis. pmid:3109295
Levin M et al. Platelet immune complex interaction in the pathogenesis of Kawasaki disease. 1987 Prog. Clin. Biol. Res. pmid:3423040
Violi F et al. Human platelet aggregation by PAF and thromboxane production. 1987 Thromb. Res. pmid:3424290
Muirhead EE Vasodepressor lipid of the renomedullary interstitial cells of the renal papilla is a prohormone activated by the liver. 1987 Agents Actions Suppl. pmid:3324720
Mest HJ et al. Relevance of eicosanoids for biochemical regulation of cardiac rhythm disturbances. 1987 Biomed. Biochim. Acta pmid:3325045
Bloom JW et al. Intravenous platelet activating factor does not affect lung epithelial permeability. 1987 Res. Commun. Chem. Pathol. Pharmacol. pmid:3326081
de Almeida PJ et al. [Biochemical bases of platelet activity in homeostasis and thrombogenesis. III]. 1987 Arq. Bras. Cardiol. pmid:3328601
Kester M et al. Elevation of cytosolic free calcium by platelet-activating factor in cultured rat mesangial cells. 1987 FASEB J. pmid:2442057
Panetta T et al. Effects of a platelet activating factor antagonist (BN 52021) on free fatty acids, diacylglycerols, polyphosphoinositides and blood flow in the gerbil brain: inhibition of ischemia-reperfusion induced cerebral injury. 1987 Biochem. Biophys. Res. Commun. pmid:2827647
HÃ¥kansson L et al. New method for the measurement of eosinophil migration. 1987 J. Leukoc. Biol. pmid:2445885
Bazan HE et al. The accumulation of platelet activating factor in the injured cornea may be interrelated with the synthesis of lipoxygenase products. 1987 Biochem. Biophys. Res. Commun. pmid:2827658
Sciberras DG et al. Inflammatory responses to intradermal injection of platelet activating factor, histamine and prostaglandin E2 in healthy volunteers: a double blind investigation. 1987 Br J Clin Pharmacol pmid:2449904
Czarnetzki BM [Mediators and the bronchial system. Pathophysiologic and biochemical aspects of mediators of the bronchial system]. 1987 Wien Med Wochenschr Suppl pmid:3078398
Schwertschlag U et al. L-platelet activating factor induces changes on renal vascular resistance, vascular reactivity, and renin release in the isolated perfused rat kidney. 1987 Circ. Res. pmid:3297384
Page CP A role for platelet activating factor and platelets in the induction of bronchial hyperreactivity. 1987 Int J Tissue React pmid:3298115
Lian EC Pathogenesis of thrombotic thrombocytopenic purpura. 1987 Semin. Hematol. pmid:3299722
Tou JS Platelet-activating factor modulates phospholipid acylation in human neutrophils. 1987 Lipids pmid:3110533
Touvay C et al. Gossypol: a potent inhibitor of PAF-acether- and leukotriene-induced contractions of guinea-pig lung parenchyma strips. 1987 J. Pharm. Pharmacol. pmid:2886603
Chung KF et al. Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man. 1987 Lancet pmid:2880069
Casals-Stenzel J and Weber KH Triazolodiazepines: dissociation of their Paf (platelet activating factor) antagonistic and CNS activity. 1987 Br. J. Pharmacol. pmid:2880622
Lagente V et al. Platelet-activating factor (PAF-acether) and microcirculation: effect of Lyso-PAF and PAF-antagonists. 1987 Braz. J. Med. Biol. Res. pmid:3452452
Gentry PA et al. Inhibitory effect of trichothecene mycotoxins on bovine platelets stimulated by platelet activating factor. 1987 Can. J. Vet. Res. pmid:3453270
Sugatani J et al. Potential involvement of vicinal sulfhydryls in stimulus-induced rabbit platelet activation. 1987 J. Biol. Chem. pmid:2824509
Spinks NR and O'Neill C Embryo-deprived platelet-activating factor is essential for establishment of pregnancy in the mouse. 1987 Lancet pmid:2432367
Evans TW et al. Effect of platelet-activating factor on airway vascular permeability: possible mechanisms. 1987 J. Appl. Physiol. pmid:3115939
Knudsen BS et al. Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells. 1987 J. Clin. Invest. pmid:3116043
Feuerstein G and Hallenbeck JM Prostaglandins, leukotrienes, and platelet-activating factor in shock. 1987 Annu. Rev. Pharmacol. Toxicol. pmid:3034139
Bussolino F et al. Human endothelial cells are target for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeleton structures. 1987 J. Immunol. pmid:3116081
Bitterman H et al. Beneficial actions of RO 15-1788, a benzodiazepine receptor antagonist, in hemorrhagic shock. 1987 Methods Find Exp Clin Pharmacol pmid:3116357
Gateau O [Role of PAF-acether (platelet activating factor) in cardio-vascular pathology]. 1987 Arch Mal Coeur Vaiss pmid:3117010
Altin JG et al. Evidence that Ca2+ fluxes and respiratory, glycogenolytic and vasoconstrictive effects induced by the action of platelet-activating factor and L-alpha-lysophosphatidylcholine in the perfused rat liver are mediated by products of the cyclo-oxygenase pathway. 1987 Biochem. J. pmid:3117040
Terashita Z et al. A lethal role of platelet activating factor in anaphylactic shock in mice. 1987 J. Pharmacol. Exp. Ther. pmid:3118009
Sperling RI et al. The effects of N-3 polyunsaturated fatty acids on the generation of platelet-activating factor-acether by human monocytes. 1987 J. Immunol. pmid:2826583
Musch MW et al. Antigen-and ionophore-stimulated synthesis of platelet-activating factor by the cloned mast cell line, MC9. 1987 Biochem. Biophys. Res. Commun. pmid:3107564
Sisson JH et al. Production of platelet-activating factor by stimulated human polymorphonuclear leukocytes. Correlation of synthesis with release, functional events, and leukotriene B4 metabolism. 1987 J. Immunol. pmid:3035016
Michel L et al. Biologic properties of LTB4 and paf-acether in vivo in human skin. 1987 J. Invest. Dermatol. pmid:3035030
Bureau M et al. Desensitization and antagonism of rat polymorphonuclear leukocytes stimulated with PAF acether. 1987 Prostaglandins pmid:3035615
Satouchi K et al. 1-Acyl-2-acetyl-sn-glycero-3-phosphocholine from stimulated human polymorphonuclear leukocytes. 1987 Lipids pmid:3110532
Di Marzo V et al. Neuropeptides and leukotriene release: effect of peptide histidine isoleucine and secretin in platelet activating factor-stimulated rat lung. 1987 Neuropeptides pmid:3031537
Liu BN [Neoplastic membrane-toxic activity as one of the pathogenetic factors in blood cell and tumor growth changes]. 1987 Jan-Feb Patol Fiziol Eksp Ter pmid:3550649
Lurie A et al. Exercise- and allergen-induced asthma do not change the production of Paf-acether by neutrophils and platelets. 1987 Jul-Aug Bull Eur Physiopathol Respir pmid:3690021
Auriault C et al. The effector function of platelets is induced and regulated by T lymphocytes. 1987 Jul-Aug Ann. Inst. Pasteur Immunol. pmid:3118905
Fiedler VB et al. Comparison of cardiac and hemodynamic effects of platelet-activating factor-acether and leukotriene D4 in anesthetized dogs. 1987 Mar-Apr Basic Res. Cardiol. pmid:3606544
Arnoux B et al. Antigenic release of paf-acether and beta-glucuronidase from alveolar macrophages of asthmatics. 1987 Mar-Apr Bull Eur Physiopathol Respir pmid:3607326
Berdel WE et al. Lack of correlation between cytotoxicity of agonists and antagonists of platelet activating factor [paf-acether] in neoplastic cells and modulation of [3H]-paf-acether binding to platelets from humans in vitro. 1987 Nov-Dec Anticancer Res. pmid:3442414
Lakin KM et al. [Action of calcium antagonists on thrombocyte aggregation]. 1987 Sep-Oct Farmakol Toksikol pmid:2826225
Hanss M and Dechavanne M 48740 RP, an antagonist of PAF, does not affect human plasma fibrinolysis before and after venous occlusion. 1988 Thromb. Res. pmid:3126559
Acker G et al. Role of platelet-activating factor (PAF) in the ovoimplantation in the rat: effect of the specific PAF-acether antagonist, BN 52021. 1988 Prostaglandins pmid:3129758
Greenberg S et al. Extracellular nucleotides mediate Ca2+ fluxes in J774 macrophages by two distinct mechanisms. 1988 J. Biol. Chem. pmid:3392016
Wallace JL and MacNaughton WK Gastrointestinal damage induced by platelet-activating factor: role of leukotrienes. 1988 Eur. J. Pharmacol. pmid:2843390
Etienne A et al. Possible involvement of platelet-activating factor in endotoxin-induced abortion. 1988 Prog. Clin. Biol. Res. pmid:3393560
Coyle AJ et al. The effect of the selective PAF antagonist BN 52021 on PAF- and antigen-induced bronchial hyper-reactivity and eosinophil accumulation. 1988 Eur. J. Pharmacol. pmid:3383997
Tokumura A et al. Study of platelet activating factor and its antagonists on rat colon strip with a new method avoiding tachyphylaxis. 1988 Eur. J. Pharmacol. pmid:3384001
Lagarde M Metabolism of fatty acids by platelets and the functions of various metabolites in mediating platelet function. 1988 Prog. Lipid Res. pmid:3060881
Freitas JC et al. Inhibition of platelet aggregation by manoalide: preliminary results. 1988 Braz. J. Med. Biol. Res. pmid:3203166
Pai JK et al. Phospholipase D catalyzes phospholipid metabolism in chemotactic peptide-stimulated HL-60 granulocytes. 1988 J. Biol. Chem. pmid:3165977
Collier M et al. Biochemical and pharmacological characterization of human embryo-derived platelet activating factor. 1988 Hum. Reprod. pmid:3204154
Armstead WM et al. Platelet activating factor: a potent constrictor of cerebral arterioles in newborn pigs. 1988 Circ. Res. pmid:3335052
Domingo MT et al. Presence of specific binding sites for platelet-activating factor (PAF) in brain. 1988 Biochem. Biophys. Res. Commun. pmid:2831903
Dillon PK et al. Vasoconstrictor effects of platelet-activating factor in the hamster cheek pouch microcirculation: dose-related relations and pathways of action. 1988 Circ. Res. pmid:2832096
Ma YH and Dunham EW Antagonism of the vasodilator effects of a platelet activating factor precursor in anesthetized spontaneously hypertensive rats. 1988 Eur. J. Pharmacol. pmid:2832188
Hasegawa T and Nakajima S [Recent topics on platelet-activating-factor (PAF)]. 1988 Nippon Ika Daigaku Zasshi pmid:3360909
Chau LY and Jii YJ Characterization of 3H-labelled platelet activating factor receptor complex solubilized from rabbit platelet membranes. 1988 Biochim. Biophys. Acta pmid:2838093
Thelen M et al. Activation of monocytes by interferon-gamma has no effect on the level or affinity of the nicotinamide adenine dinucleotide-phosphate oxidase and on agonist-dependent superoxide formation. 1988 J. Clin. Invest. pmid:2838524
Errasfa M et al. Inhibition of phospholipase A2 activity of guinea-pig alveolar macrophages by lipocortin-like proteins purified from mice lung. 1988 Biochem. Biophys. Res. Commun. pmid:2968795
Eliakim R et al. Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone. 1988 Gastroenterology pmid:2901995
Lellouch-Tubiana A et al. Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Modulation by prostacyclin, platelet depletion, and selective antagonists. 1988 Am. Rev. Respir. Dis. pmid:3281530
Chung KF and Barnes PJ PAF antagonists. Their potential therapeutic role in asthma. 1988 Drugs pmid:3281823